← All trials
NCT05911906
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 1, 2024
- Primary completion
- Oct 1, 2025
- Completion date
- Dec 1, 2025
- First posted
- Jun 22, 2023
- Last posted
- Dec 27, 2023
- Enrollment
- 72
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of DerbyLead sponsor
- Derby Hospitals NHS Foundation TrustCollaborator
- University of DerbyReponsible party - principal investigator
- University of ExeterCollaborator
- University of PlymouthCollaborator
- University of DerbySponsor investigator
- Aston UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.